Advertisement
Review Article| Volume 30, ISSUE 3, P643-654, September 2010

Screening and Testing in Multiples

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Evans MI, Britt DW. Selective reduction in multifetal pregnancies In: Paul M, Grimes D, Stubblefield P. et al, editors. Management of unintended and abnormal pregnancy. London: Blackwell-Wiley; 2009. p. 312–8.

        • Russell R.B.
        • Petrini J.R.
        • Damus K.
        • et al.
        The changing epidemiology of multiple births in the United States.
        Obstet Gynecol. 2003; 101: 129-135
        • Evans M.I.
        • Yaron Y.
        • Wapner R.J.
        CVS.
        in: Evans M.I. Johnson M.P. Yaron Y. Prenatal diagnosis: genetics, reproductive risks, testing, and management. McGraw-Hill, New York2006: 433-442
        • Spencer K.
        • Nicolaides K.H.
        Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
        BJOG. 2003; 110: 276-280
        • Luke B.
        Monozygotic twinning as a congenital defect and congenital defects in monozygotic twins.
        Fetal Diagn Ther. 1990; 5: 61-69
        • Holmes A.
        • Jauniaux E.
        Prospective study of parental choice for aneuploidy screening in assisted conception versus spontaneously conceived twins.
        Reprod Biomed Online. 2004; 8: 243-245
        • Geipel A.
        • Berg C.
        • Katalinic A.
        • et al.
        Different preferences for prenatal diagnosis in pregnancies following assisted reproduction versus spontaneous conception.
        Reprod Biomed Online. 2004; 8: 119-124
        • Brambati B.
        • Tului L.
        • Alberti E.
        Prenatal diagnosis by chorionic villus sampling.
        Eur J Obstet Gynecol Reprod Biol. 1996; 65: 11-16
        • Alfirevic Z.
        • Sundberg K.
        • Brigham S.
        Amniocentesis and chorionic villus sampling for prenatal diagnosis.
        Cochrane Database Syst Rev. 2003; 3 (CD003252)
        • Alfirevic Z.
        • Tabor A.
        Pregnancy loss rates after midtrimester amniocentesis.
        Obstet Gynecol. 2007; 109: 1203-1204
        • Mujezinovic F.
        • Alfirevic Z.
        Procedure related complications of amniocentesis and chorionic villus sampling.
        Obstet Gynecol. 2007; 110: 687-694
        • Yaron Y.
        • Bryant-Greenwood P.K.
        • Dave N.
        • et al.
        Multifetal pregnancy reductions of triplets to twins: comparison with nonreduced triplets and twins.
        Am J Obstet Gynecol. 1999; 180: 1268-1271
        • Sepulveda W.
        • Sebire N.J.
        • Hughes K.
        • et al.
        The lambda sign at 10–14 weeks of gestation as a predictor of chorionicity in twin pregnancies.
        Ultrasound Obstet Gynecol. 1996; 7: 421-423
        • Vayssiere C.F.
        • Heim N.
        • Camus E.P.
        • et al.
        Determination of chorionicity in twin gestations by high-frequency abdominal ultrasonography: counting the layers of the dividing membrane.
        Am J Obstet Gynecol. 1996; 175: 1529-1533
        • Evans M.I.
        • Galen R.S.
        • Drugan A.
        Biochemical screening.
        in: Evans M.I. Johnson M.P. Yaron Y. Prenatal diagnosis: genetics, reproductive risks, testing, and management. McGraw-Hill, New York2006: 277-288
        • Wald N.J.
        • Rish S.
        • Hackshaw A.K.
        Combining nuchal translucency and maternal serum markers in prenatal screening for Down Syndrome in twin pregnancies.
        Prenat Diagn. 2000; 23: 588-592
        • Sebire N.J.
        • Snijders R.J.M.
        • Hughes K.
        • et al.
        Screening for Trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation.
        Br J Obstet Gynaecol. 1996; 103: 999-1003
        • Obrien J.E.
        • Dvorin E.
        • Yaron Y.
        • et al.
        Differential increases in AFP, hCG, and uE3 in twin pregnancies: impact on attempts to quantify Down Syndrome screening calculations.
        Am J Med Genet. 1997; 73: 109-112
        • Cleary-Goldman J.
        • Berkowitz R.L.
        First trimester screening for Down Syndrome in multiple pregnancy.
        Semin Perinatol. 2005; 29: 395-400
        • Henry G.P.
        • Britt D.W.
        • Evans M.I.
        Screening advances and diagnostic choice: the problem of residual risk.
        Fetal Diagn Ther. 2008; 23: 308-315
        • Wald N.J.
        • Rodeck C.
        • Hackshaw A.K.
        • et al.
        SURUSS in perspective.
        Br J Obstet Gynaecol. 2004; 111: 521-531
        • Gonce A.
        • Borrell A.
        • Fortuny A.
        • et al.
        First trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?.
        Prenat Diagn. 2005; 25: 1156-1161
        • Evans M.I.
        • Van Decruyes H.
        • Nicolaides K.H.
        Nuchal translucency (NT) measurements for 1st trimester screening: the "price" of inaccuracy.
        Fetal Diagn Ther. 2007; 22: 401-404
        • Bang J.
        • Nielsen H.
        • Philip J.
        Prenatal karyotyping of twins by ultrasonically guided amniocentesis.
        Am J Obstet Gynecol. 1975; 123: 695-696
        • Nicolini U.
        • Monni G.
        Intestinal obstruction in babies exposed in utero to methylene blue.
        Lancet. 1990; 336: 1258-1259
        • Cragan J.D.
        • Martin M.L.
        • Khoury M.J.
        • et al.
        Dye use during amniocentesis and birth defects.
        Lancet. 1993; 341: 1352
        • Jeanty P.
        • Shah D.
        • Roussis P.
        Single-needle insertion in twin amniocentesis.
        J Ultrasound Med. 1990; 9: 511-517
        • Machin G.A.
        Some causes of genotypic and phenotypic discordance in monozygotic twin pairs.
        Am J Med Genet. 1996; 61: 216-228
        • Evans M.I.
        • Rodeck C.H.
        • Johnson M.P.
        • et al.
        Selective termination in Evans MI.
        in: Johnson M.P. Yaron Y. Drugan A. Prenatal diagnosis: genetics, reproductive risks, testing, and management. McGraw-Hill, New York2006: 571-578
        • Nieuwint A.
        • Zalen-Sprock R.
        • Hummel P.
        • et al.
        ‘Identical’ twins with discordant karyotypes.
        Prenat Diagn. 1999; 19: 72-76
        • Evans M.I.
        • Wapner R.J.
        Invasive prenatal diagnostic procedures 2005.
        in: Reddy U. Mennuti M.T. Seminars in perinatology. 29. Elsevier, 2005: 215-218
        • Eddleman K.A.
        • Malone F.D.
        • Sullivan L.
        • et al.
        Pregnancy loss rates after midtrimester amniocentesis.
        Obstet Gynecol. 2006; 108: 1067-1072
        • Wapner R.J.
        • Evans M.I.
        • Platt L.D.
        Pregnancy loss rates after midtrimester amniocentesis.
        Obstet Gynecol. 2007; 109: 780
        • Tabor A.
        • Philip J.
        • Madsen M.
        • et al.
        Randomised controlled trial of genetic amniocentesis in 4606 low-risk women.
        Lancet. 1986; 1: 1287-1293
        • De Catte L.
        • Foulon W.
        Obstetric outcome after fetal reduction to singleton pregnancies.
        Prenat Diagn. 2002; 22: 206-210
        • Evans M.I.
        • Kaufman M.
        • Urban A.J.
        • et al.
        Fetal reduction from twins to a singleton: a reasonable consideration.
        Obstet Gynecol. 2004; 104: 102-109
        • Wapner R.J.
        • Johnson A.
        • Davis G.
        • et al.
        Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling.
        Obstet Gynecol. 1993; 82: 49-56
        • Rhoads G.G.
        • Jackson L.G.
        • Schlesselman S.E.
        • et al.
        The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities.
        N Engl J Med. 1989; 320: 609-617
        • Brambati B.
        • Tului L.
        • Guercilena S.
        • et al.
        Outcome of first-trimester chorionic villus sampling for genetic investigation in multiple pregnancy.
        Ultrasound Obstet Gynecol. 2001; 17: 209-216
        • Caughey A.B.
        • Hopkins L.M.
        • Norton M.E.
        Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss.
        Obstet Gynecol. 2006; 108: 612-616
        • Brambati B.
        • Tului L.
        • Baldi M.
        • et al.
        Genetic analysis prior to selective fetal reduction in multiple pregnancy: technical aspects and clinical outcome.
        Humanit Rep. 1995; 10: 818-825
        • Jenkins T.M.
        • Wapner R.J.
        The challenge of prenatal diagnosis in twin pregnancies.
        Curr Opin Obstet Gynecol. 2000; 12: 87-92
        • Britt D.W.
        • Evans M.I.
        Sometimes doing the right thing sucks: frame combinations and multifetal pregnancy reduction decision difficulty.
        Soc Sci Med. 2007; 65: 2342-2356